Africa mRNA Vaccines and RNAi Therapeutics Market (2025-2031) | Demand, Restraints, Investment Trends, Outlook, Competition, Pricing Analysis, Industry, Supply, Strategy, Competitive, Opportunities, Growth, Size, Forecast, Drivers, Strategic Insights, Segmentation, Consumer Insights, Analysis, Companies, Value, Challenges, Trends, Segments, Share, Revenue

Market Forecast by Countries (South Africa, Egypt, Nigeria, and Rest of Africa), By Disease Type (Hereditary transthyretin-mediated amyloidosis genetic, Acute hepatic porphyria, Primary hyperoxaluria type 1, Atherosclerotic cardiovascular disease), By Administration (IV infusion, Subcutaneous), By End user (Research Institutes, Hospitals and Clinics) And Competitive Landscape
Product Code: ETC13140002 Publication Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 150 No. of Figures: 55 No. of Tables: 32

Key Highlights of the Report:

  • Africa mRNA Vaccines and RNAi Therapeutics Market Outlook
  • Market Size of Africa mRNA Vaccines and RNAi Therapeutics Market, 2024
  • Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market, 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Revenues & Volume for the Period 2021 - 2031
  • Africa mRNA Vaccines and RNAi Therapeutics Market Trend Evolution
  • Africa mRNA Vaccines and RNAi Therapeutics Market Drivers and Challenges
  • Africa mRNA Vaccines and RNAi Therapeutics Price Trends
  • Africa mRNA Vaccines and RNAi Therapeutics Porter's Five Forces
  • Africa mRNA Vaccines and RNAi Therapeutics Industry Life Cycle
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021 - 2031
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Key Performance Indicators
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Import Export Trade Statistics
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment By Countries
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment By Disease Type
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment By Administration
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment By End user
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Top Companies Market Share
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Top Companies Profiles
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Comparison of Players in Technical and Operating Parameters
  • Africa mRNA Vaccines and RNAi Therapeutics Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Africa mRNA Vaccines and RNAi Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Africa mRNA Vaccines and RNAi Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Africa mRNA Vaccines and RNAi Therapeutics Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Africa mRNA Vaccines and RNAi Therapeutics Market Overview

3.1 Africa Regional Macro Economic Indicators

3.2 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Africa mRNA Vaccines and RNAi Therapeutics Market - Industry Life Cycle

3.4 Africa mRNA Vaccines and RNAi Therapeutics Market - Porter's Five Forces

3.5 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.7 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Administration, 2021 & 2031F

3.8 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F

4 Africa mRNA Vaccines and RNAi Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Africa mRNA Vaccines and RNAi Therapeutics Market Trends

6 Africa mRNA Vaccines and RNAi Therapeutics Market, 2021 - 2031

6.1 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Hereditary transthyretin-mediated amyloidosis genetic, 2021 - 2031

6.1.3 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Acute hepatic porphyria, 2021 - 2031

6.1.4 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Primary hyperoxaluria type 1, 2021 - 2031

6.1.5 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Atherosclerotic cardiovascular disease, 2021 - 2031

6.2 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Administration, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By IV infusion, 2021 - 2031

6.2.3 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Subcutaneous, 2021 - 2031

6.3 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Research Institutes, 2021 - 2031

6.3.3 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031

7 Africa mRNA Vaccines and RNAi Therapeutics Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.1 South Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.2 Egypt mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.3 Nigeria mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.2.4 Rest of Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.3 Africa mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Administration, 2021 & 2031F

7.3.1 South Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Administration, 2021 - 2031

7.3.2 Egypt mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Administration, 2021 - 2031

7.3.3 Nigeria mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Administration, 2021 - 2031

7.3.4 Rest of Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By Administration, 2021 - 2031

7.4 Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

7.4.1 South Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

7.4.2 Egypt mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

7.4.3 Nigeria mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

7.4.4 Rest of Africa mRNA Vaccines and RNAi Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031

8 Africa mRNA Vaccines and RNAi Therapeutics Market Key Performance Indicators

9 Africa mRNA Vaccines and RNAi Therapeutics Market - Export/Import By Countries Assessment

10 Africa mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment

10.1 Africa mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 Africa mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F

10.3 Africa mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Administration, 2021 & 2031F

10.4 Africa mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F

11 Africa mRNA Vaccines and RNAi Therapeutics Market - Competitive Landscape

11.1 Africa mRNA Vaccines and RNAi Therapeutics Market Revenue Share, By Companies, 2022

11.2 Africa mRNA Vaccines and RNAi Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All